Renalytix Plc
RNLXY
$1.24
-$0.13-9.19%
OTC PK
| 12/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 18.10% | 8.64% | 8.74% | 16.44% |
| Total Depreciation and Amortization | -- | -200.00% | -157.97% | -36.11% | -14.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -58.39% | -2.84% | 342.13% | -75.81% |
| Change in Net Operating Assets | 0.00% | -3,288.37% | -485.69% | 6,216.67% | 99.15% |
| Cash from Operations | 0.00% | -68.51% | -60.96% | 38.60% | 16.68% |
| Capital Expenditure | 0.00% | -- | 66.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -- | 66.67% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | 100.00% | 43.40% |
| Issuance of Common Stock | 0.00% | 80,234.78% | 66.82% | 5,353.76% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 35.32% | -- | 100.00% |
| Cash from Financing | 0.00% | 65,017.39% | 93.13% | 895.46% | 52.39% |
| Foreign Exchange rate Adjustments | 0.00% | -676.19% | 116.87% | -153.90% | 169.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 319.33% | 97.38% | 88.94% | 23.34% |